Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline
This document represents an update of the British Society for Haematology (BSH) guideline on myelofibrosis (MF) first published in 2012 and updated in 2015.1 This guideline aims to provide healthcare professionals with clear guidance on the diagnosis and prognostic evaluation of primary myelofibrosi...
المؤلفون الرئيسيون: | McLornan, DP, Godfrey, AL, Green, A, Frewin, R, Arami, S, Brady, J, Butt, NM, Cargo, C, Ewing, J, Francis, S, Garg, M, Harrison, C, Innes, A, Khan, A, Knapper, S, Lambert, J, Mead, A, McGregor, A, Neelakantan, P, Psaila, B, Somervaille, TCP, Woodley, C, Nangalia, J, Cross, NCP, McMullin, MF |
---|---|
مؤلفون آخرون: | BSH Committee |
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Wiley
2023
|
مواد مشابهة
-
A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline
حسب: McMullin, M, وآخرون
منشور في: (2018) -
A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis
حسب: McMullin, M, وآخرون
منشور في: (2018) -
Allogeneic stem cell transplantation for myelofibrosis in 2012.
حسب: McLornan, D, وآخرون
منشور في: (2012) -
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.
حسب: Reilly, J, وآخرون
منشور في: (2014) -
Guideline for the diagnosis and management of myelofibrosis.
حسب: Reilly, J, وآخرون
منشور في: (2012)